Review of the European Society of Cardiology (ESC) Congress 2022

Abstract

AFTER 2 years of virtual meetings, the European Society of Cardiology (ESC) adopted a pioneering hybrid format for its 2022 congress, allowing delegates from across the globe to meet onsite in Barcelona, Spain, and also online. Clinicians and academics came together with one common goal: to advance cardiovascular care and improve patient outcomes. This was emphasised by Stephan Achenbach, ESC President, who commented: “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective clinical experience. This is how true progress in cardiovascular medicine is made.” Achenbach spoke about the rapid pace of innovation and advancement since the first doubleblind randomised trial in cardiovascular medicine was completed in 1971. “Numerous large trials are published every year, often practice-changing, and many are first presented at ESC Congress,” he emphasised.